<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1 20151215//EN" "https://jats.nlm.nih.gov/publishing/1.1/JATS-journalpublishing1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" specific-use="sps-1.9" dtd-version="1.1" xml:lang="pt" article-type="research-article">
  <front>
    <journal-meta>
      <journal-id journal-id-type="publisher-id">abc</journal-id>
      <journal-title-group>
        <journal-title>Arquivos Brasileiros de Cardiologia</journal-title>
        <abbrev-journal-title abbrev-type="publisher">Arq. Bras. Cardiol.</abbrev-journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0066-782X</issn>
      <issn pub-type="epub">1678-4170</issn>
      <publisher>
        <publisher-name>Sociedade Brasileira de Cardiologia - SBC</publisher-name>
        <publisher-loc>S&#227;o Paulo, SP, Brazil</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="publisher-id" specific-use="scielo-v3">H8m5qbHy5wtqnJCRhhwwqbn</article-id>
      <article-id pub-id-type="other">00001</article-id>
      <article-id pub-id-type="publisher-id" specific-use="scielo-v2">S0066-782X2007000500001</article-id>
      <article-id pub-id-type="publisher-id" specific-use="scielo-v1">S0066-782X(07)08800501</article-id>
      <article-id pub-id-type="doi">10.1590/S0066-782X2007000500001</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Artigos Originais</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Vers&#227;o em portugu&#234;s, adapta&#231;&#227;o transcultural e valida&#231;&#227;o do Question&#225;rio de Claudica&#231;&#227;o de Edimburgo</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Makdisse</surname>
            <given-names>Marcia</given-names>
          </name>
          <xref ref-type="aff" rid="aff01"/>
          <xref ref-type="aff" rid="aff02"/>
          <xref ref-type="aff" rid="aff03"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Nascimento Neto</surname>
            <given-names>Raimundo</given-names>
          </name>
          <xref ref-type="aff" rid="aff01"/>
          <xref ref-type="aff" rid="aff02"/>
          <xref ref-type="aff" rid="aff03"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Chagas</surname>
            <given-names>Antonio Carlos Palandri</given-names>
          </name>
          <xref ref-type="aff" rid="aff01"/>
          <xref ref-type="aff" rid="aff02"/>
          <xref ref-type="aff" rid="aff03"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Brasil</surname>
            <given-names>David</given-names>
          </name>
          <xref ref-type="aff" rid="aff01"/>
          <xref ref-type="aff" rid="aff02"/>
          <xref ref-type="aff" rid="aff03"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Borges</surname>
            <given-names>Jairo Lins</given-names>
          </name>
          <xref ref-type="aff" rid="aff01"/>
          <xref ref-type="aff" rid="aff02"/>
          <xref ref-type="aff" rid="aff03"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Oliveira</surname>
            <given-names>Anderson</given-names>
          </name>
          <xref ref-type="aff" rid="aff01"/>
          <xref ref-type="aff" rid="aff02"/>
          <xref ref-type="aff" rid="aff03"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Gordillo</surname>
            <given-names>Jos&#233;</given-names>
          </name>
          <xref ref-type="aff" rid="aff01"/>
          <xref ref-type="aff" rid="aff02"/>
          <xref ref-type="aff" rid="aff03"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Balsalobre</surname>
            <given-names>Gisele</given-names>
          </name>
          <xref ref-type="aff" rid="aff01"/>
          <xref ref-type="aff" rid="aff02"/>
          <xref ref-type="aff" rid="aff03"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Crozariol</surname>
            <given-names>Luciana</given-names>
          </name>
          <xref ref-type="aff" rid="aff01"/>
          <xref ref-type="aff" rid="aff02"/>
          <xref ref-type="aff" rid="aff03"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Pinho</surname>
            <given-names>Miriam</given-names>
          </name>
          <xref ref-type="aff" rid="aff01"/>
          <xref ref-type="aff" rid="aff02"/>
          <xref ref-type="aff" rid="aff03"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Oliveira</surname>
            <given-names>Rafaela</given-names>
          </name>
          <xref ref-type="aff" rid="aff01"/>
          <xref ref-type="aff" rid="aff02"/>
          <xref ref-type="aff" rid="aff03"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Salles</surname>
            <given-names>Ana F&#225;tima</given-names>
          </name>
          <xref ref-type="aff" rid="aff01"/>
          <xref ref-type="aff" rid="aff02"/>
          <xref ref-type="aff" rid="aff03"/>
        </contrib>
      </contrib-group>
      <aff id="aff02">
        <addr-line>
          <named-content content-type="state">S&#227;o Paulo</named-content>
        </addr-line>
        <institution content-type="orgname">Universidade Federal de S&#227;o Paulo</institution>
        <institution content-type="orgdiv1">Setor de Cardiogeriatria </institution>
        <country country="BR">Brazil</country>
      </aff>
      <aff id="aff03">
        <addr-line>
          <named-content content-type="city">S&#227;o Paulo</named-content>
          <named-content content-type="state">SP</named-content>
        </addr-line>
        <institution content-type="orgname">Hospital Israelita Albert Einstein</institution>
      </aff>
      <aff id="aff01">
        <institution content-type="orgname">SBC</institution>
      </aff>
      <pub-date date-type="collection" publication-format="electronic">
        <month>05</month>
        <year>2007</year>
      </pub-date>
      <volume>88</volume>
      <issue>5</issue>
      <fpage>501</fpage>
      <lpage>506</lpage>
      <history>
        <date date-type="received">
          <day>13</day>
          <month>07</month>
          <year>2006</year>
        </date>
        <date date-type="rev-recd">
          <day>06</day>
          <month>11</month>
          <year>2006</year>
        </date>
        <date date-type="accepted">
          <day>17</day>
          <month>01</month>
          <year>2007</year>
        </date>
      </history>
      <permissions>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/4.0/" xml:lang="en">
          <license-p>This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.</license-p>
        </license>
      </permissions>
      <abstract>
        <p>OBJETIVO: Traduzir, adaptar culturalmente e validar a vers&#227;o em portugu&#234;s do Question&#225;rio de Claudica&#231;&#227;o de Edimburgo, espec&#237;fico para avaliar a presen&#231;a de claudica&#231;&#227;o intermitente. M&#201;TODOS: A vers&#227;o em portugu&#234;s do Question&#225;rio de Claudica&#231;&#227;o de Edimburgo foi desenvolvida, ap&#243;s autoriza&#231;&#227;o da Universidade de Edimburgo, e aplicada em 217 indiv&#237;duos residentes no munic&#237;pio de S&#227;o Paulo, com queixas de dor nas pernas, convidados pelos meios de comunica&#231;&#227;o de massa a participar da I Campanha de Combate &#224; Doen&#231;a Arterial Obstrutiva Perif&#233;rica (DAOP). Na primeira etapa, eles responderam ao Question&#225;rio de Claudica&#231;&#227;o de Edimburgo e a um question&#225;rio sobre fatores de risco e antecedentes cardiovasculares. Na segunda etapa, realizaram medidas antropom&#233;tricas e do &#237;ndice tornozelo-braquial (ITB) de repouso com Doppler vascular e, nos casos duvidosos, teste de esfor&#231;o vascular em esteira (TEV). A presen&#231;a de DAOP foi definida por ITB &lt; 0,90 e/ou por TEV positivo e/ou por DAOP documentada. A an&#225;lise estat&#237;stica, que incluiu avalia&#231;&#227;o de desempenho e compara&#231;&#245;es das propor&#231;&#245;es e m&#233;dias, foi realizada utilizando-se o programa SAS vers&#227;o 8.2. RESULTADOS: A m&#233;dia de idade dos participantes foi de 60 &#177; 11,5 anos, com predom&#237;nio do sexo feminino (53,4%). A an&#225;lise de desempenho da vers&#227;o em l&#237;ngua portuguesa mostrou sensibilidade de 85%, especificidade de 93%, valor preditivo positivo de 80%, valor preditivo negativo de 95% e acur&#225;cia de 91%. N&#227;o houve diferen&#231;a no desempenho entre idosos (&gt; 65 anos) e n&#227;o-idosos. CONCLUS&#195;O: A vers&#227;o em portugu&#234;s do Question&#225;rio de Claudica&#231;&#227;o de Edimburgo manteve n&#237;veis adequados de sensibilidade e especificidade, podendo ser recomendado para o rastreamento de DAOP na pr&#225;tica cl&#237;nica e em estudos epidemiol&#243;gicos realizados no Brasil.</p>
      </abstract>
      <kwd-group xml:lang="pt" kwd-group-type="author-generated">
        <kwd>Claudica&#231;&#227;o intermitente</kwd>
        <kwd>question&#225;rio</kwd>
        <kwd>tradu&#231;&#227;o</kwd>
        <kwd>adapta&#231;&#227;o transcultural</kwd>
      </kwd-group>
      <pub-date publication-format="electronic" date-type="pub">
        <day>15</day>
        <month>06</month>
        <year>2007</year>
      </pub-date>
    </article-meta>
  </front>
  <body>
    <p>
      <bold>ARTIGO ORIGINAL</bold>
    </p>
    <p>
      <bold>Vers&#227;o em portugu&#234;s, adapta&#231;&#227;o transcultural e valida&#231;&#227;o do Question&#225;rio de Claudica&#231;&#227;o de Edimburgo</bold>
    </p>
    <p>
      <bold>Marcia Makdisse; Raimundo Nascimento Neto; Antonio Carlos Palandri Chagas; David Brasil; Jairo Lins Borges; Anderson Oliveira; Jos&#233; Gordillo; Gisele Balsalobre; Luciana Crozariol; Miriam Pinho; Rafaela Oliveira; Ana F&#225;tima Salles</bold>
    </p>
    <p> Comit&#234; de Doen&#231;a Arterial Perif&#233;rica do "Projeto Cora&#231;&#245;es do Brasil" (SBC/Funcor)/Setor de Cardiogeriatria, Disciplina de Cardiologia, Universidade Federal de S&#227;o Paulo/Hospital Israelita Albert Einstein &#150; S&#227;o Paulo, SP</p>
    <p>
      <xref ref-type="corresp" rid="end">Correspond&#234;ncia</xref>
    </p>
    <p>
      <bold>RESUMO</bold>
    </p>
    <p><bold>OBJETIVO: </bold>Traduzir, adaptar culturalmente e validar a vers&#227;o em portugu&#234;s do Question&#225;rio de Claudica&#231;&#227;o de Edimburgo, espec&#237;fico para avaliar a presen&#231;a de claudica&#231;&#227;o intermitente. </p>
    <p><bold>M&#201;TODOS: </bold>A vers&#227;o em portugu&#234;s do Question&#225;rio de Claudica&#231;&#227;o de Edimburgo foi desenvolvida, ap&#243;s autoriza&#231;&#227;o da Universidade de Edimburgo, e aplicada em 217 indiv&#237;duos residentes no munic&#237;pio de S&#227;o Paulo, com queixas de dor nas pernas, convidados pelos meios de comunica&#231;&#227;o de massa a participar da I Campanha de Combate &#224; Doen&#231;a Arterial Obstrutiva Perif&#233;rica (DAOP). Na primeira etapa, eles responderam ao Question&#225;rio de Claudica&#231;&#227;o de Edimburgo e a um question&#225;rio sobre fatores de risco e antecedentes cardiovasculares. Na segunda etapa, realizaram medidas antropom&#233;tricas e do &#237;ndice tornozelo-braquial (ITB) de repouso com Doppler vascular e, nos casos duvidosos, teste de esfor&#231;o vascular em esteira (TEV). A presen&#231;a de DAOP foi definida por ITB <underline>&lt;</underline> 0,90 e/ou por TEV positivo e/ou por DAOP documentada. A an&#225;lise estat&#237;stica, que incluiu avalia&#231;&#227;o de desempenho e compara&#231;&#245;es das propor&#231;&#245;es e m&#233;dias, foi realizada utilizando-se o programa SAS vers&#227;o 8.2. </p>
    <p><bold>RESULTADOS: </bold>A m&#233;dia de idade dos participantes foi de 60 &#177; 11,5 anos, com predom&#237;nio do sexo feminino (53,4%). A an&#225;lise de desempenho da vers&#227;o em l&#237;ngua portuguesa mostrou sensibilidade de 85%, especificidade de 93%, valor preditivo positivo de 80%, valor preditivo negativo de 95% e acur&#225;cia de 91%. N&#227;o houve diferen&#231;a no desempenho entre idosos (<underline>&gt;</underline> 65 anos) e n&#227;o-idosos. </p>
    <p><bold>CONCLUS&#195;O: </bold>A vers&#227;o em portugu&#234;s do Question&#225;rio de Claudica&#231;&#227;o de Edimburgo manteve n&#237;veis adequados de sensibilidade e especificidade, podendo ser recomendado para o rastreamento de DAOP na pr&#225;tica cl&#237;nica e em estudos epidemiol&#243;gicos realizados no Brasil.</p>
    <p><bold>Palavras-chave: </bold>Claudica&#231;&#227;o intermitente, question&#225;rio, tradu&#231;&#227;o (processo), adapta&#231;&#227;o transcultural.</p>
    <p>
      <bold>Introdu&#231;&#227;o</bold>
    </p>
    <p>A doen&#231;a arterial obstrutiva perif&#233;rica (DAOP) resulta do estreitamento e do enrijecimento da luz das art&#233;rias dos membros inferiores, como parte do processo de doen&#231;a ateroscler&#243;tica vascular sist&#234;mica. Tem alta preval&#234;ncia e est&#225; associada a elevado risco de eventos cardiovasculares fatais e n&#227;o-fatais (morte, infarto do mioc&#225;rdio e acidente vascular cerebral)<sup>1,2</sup>.</p>
    <p>A claudica&#231;&#227;o intermitente &#233; o sintoma cl&#225;ssico da DAOP e resulta da redu&#231;&#227;o do aporte de fluxo sangu&#237;neo para o tecido muscular esquel&#233;tico dos membros inferiores durante o exerc&#237;cio. A claudica&#231;&#227;o se caracteriza por dor ou desconforto em panturrilha, coxa ou regi&#227;o gl&#250;tea, que ocorre durante a caminhada e que desaparece em menos de 10 minutos de repouso. Na popula&#231;&#227;o geral, sua preval&#234;ncia varia de 0,4% a 14,4%, na depend&#234;ncia das caracter&#237;sticas da popula&#231;&#227;o avaliada (idade, sexo e regi&#227;o, entre outros fatores) e do m&#233;todo diagn&#243;stico utilizado<sup>3</sup>.</p>
    <p>O &#237;ndice tornozelo-braquial (ITB) &#233; o m&#233;todo padr&#227;o de refer&#234;ncia para o rastreamento da DAOP, uma vez que detecta tanto casos sintom&#225;ticos como assintom&#225;ticos da doen&#231;a<sup>4</sup>. A utiliza&#231;&#227;o de question&#225;rios de claudica&#231;&#227;o, no entanto, pode auxiliar no rastreamento da DAOP tanto em pesquisas epidemiol&#243;gicas como na pr&#225;tica cl&#237;nica. Atualmente n&#227;o dispomos de question&#225;rios de claudica&#231;&#227;o validados em l&#237;ngua portuguesa para uso no Brasil. No Projeto Bambu&#237;, que avaliou a preval&#234;ncia de claudica&#231;&#227;o intermitente em residentes de Bambu&#237;, no Estado de Minas Gerais, foi utilizada uma vers&#227;o em l&#237;ngua portuguesa do Question&#225;rio da Organiza&#231;&#227;o Mundial da Sa&#250;de, por&#233;m n&#227;o foram encontrados dados publicados referentes &#224; valida&#231;&#227;o e ao desempenho desse question&#225;rio em portugu&#234;s<sup>5</sup>.</p>
    <p>O objetivo do presente estudo foi traduzir, adaptar culturalmente e validar a vers&#227;o em portugu&#234;s do Question&#225;rio de Claudica&#231;&#227;o de Edimburgo. </p>
    <p>
      <bold>M&#233;todos</bold>
    </p>
    <p><italic>Tradu&#231;&#227;o do question&#225;rio</italic> - A tradu&#231;&#227;o e a adapta&#231;&#227;o cultural da vers&#227;o original para o portugu&#234;s foram realizadas com base em m&#233;todo previamente publicado<sup>6</sup>, ap&#243;s ter sido obtida autoriza&#231;&#227;o do Professor Gerry Fowkes, da Universidade de Edimburgo. A tradu&#231;&#227;o foi realizada de forma independente por tr&#234;s membros de nossa equipe e por dois professores de ingl&#234;s. Como resultado, foram obtidas cinco vers&#245;es, com pequenas diferen&#231;as, que foram comparadas e discutidas em uma reuni&#227;o de consenso que resultou na vers&#227;o 1. Essa vers&#227;o foi ent&#227;o enviada a tr&#234;s outros tradutores independentes, fluentes em ingl&#234;s, que n&#227;o conheciam o texto original, e que fizeram a vers&#227;o do texto em portugu&#234;s para o ingl&#234;s. Essas tr&#234;s novas vers&#245;es foram ent&#227;o comparadas e originaram uma vers&#227;o inglesa consensual (vers&#227;o 2). Ao ser comparada &#224; vers&#227;o original, a vers&#227;o 2 mostrou-se equivalente gramaticalmente e semanticamente, o que permitiu que a vers&#227;o 1 fosse aceita pelo grupo como a vers&#227;o final do question&#225;rio em portugu&#234;s.</p>
    <p>
      <bold>Valida&#231;&#227;o do question&#225;rio</bold>
    </p>
    <p><italic>Popula&#231;&#227;o - </italic>O question&#225;rio traduzido foi aplicado a 217 indiv&#237;duos residentes no munic&#237;pio de S&#227;o Paulo, com queixas de dor nas pernas, convidados pelos meios de comunica&#231;&#227;o de massa (televis&#227;o, r&#225;dio e jornal) a participar da I Campanha de Combate &#224; Doen&#231;a Arterial Obstrutiva Perif&#233;rica. Na primeira fase da campanha, realizada em 20 de julho de 2004, todos os participantes responderam ao question&#225;rio de claudica&#231;&#227;o e a um question&#225;rio sobre fatores de risco e antecedentes cardiovasculares. Na segunda etapa, ocorrida nos meses de outubro e novembro de 2004, foram realizadas medidas antropom&#233;tricas, medida do ITB e, nos casos com valores lim&#237;trofes de ITB, teste de esfor&#231;o vascular (TEV). A presen&#231;a de DAOP foi definida como ITB <underline>&lt;</underline> 0,90 e/ou TEV POSITIVO e/ou DAOP documentada. Todos os participantes assinaram termo de consentimento livre esclarecido.</p>
    <p><italic>Medida e c&#225;lculo do &#237;ndice tornozelo-braquial - </italic>Para o c&#225;lculo do ITB, as press&#245;es sist&#243;licas das art&#233;rias braquiais, pediosas e tibiais posteriores foram medidas bilateralmente, ap&#243;s cinco minutos de repouso em posi&#231;&#227;o supina, com o aux&#237;lio de Doppler vascular e aparelho de press&#227;o aner&#243;ide. Foram utilizados quatro tamanhos de manguito (adulto pequeno porte, adulto m&#233;dio porte, adulto grande porte e coxa), selecionados a partir da circunfer&#234;ncia do bra&#231;o direito, medida no ponto m&#233;dio entre o acr&#244;mio e o olecrano. Um valor de ITB foi calculado para cada membro inferior utilizando-se a maior press&#227;o sist&#243;lica dos bra&#231;os como denominador e a maior press&#227;o de tornozelo como numerador<sup>7</sup>. </p>
    <p><italic>Teste de esfor&#231;o vascular - </italic>O TEV foi realizado apenas nos casos que apresentavam valores lim&#237;trofes de ITB em repouso (0,91 a 0,94). Para a realiza&#231;&#227;o do TEV, foi utilizado protocolo incremental em esteira rolante, com velocidade de 3 km/h, inclina&#231;&#227;o de 0% a 15%, com incrementos de 5% a cada tr&#234;s minutos. As press&#245;es foram medidas com <italic>Doppler</italic> vascular, na posi&#231;&#227;o supina, em repouso e ap&#243;s o esfor&#231;o. O teste foi considerado POSITIVO para o diagn&#243;stico de DAOP se ocorresse queda da press&#227;o sist&#243;lica de tornozelo, medida no primeiro minuto ap&#243;s o esfor&#231;o, maior ou igual a 20% em rela&#231;&#227;o ao valor basal, e tempo de recupera&#231;&#227;o dos n&#237;veis basais superior a tr&#234;s minutos<sup>8</sup>.</p>
    <p><italic>Crit&#233;rios de exclus&#227;o - </italic>Foram exclu&#237;dos da an&#225;lise os pacientes com ITB &gt; 1,40 (art&#233;rias n&#227;o compress&#237;veis) e os que apresentaram limita&#231;&#227;o ou contra-indica&#231;&#227;o &#224; prova de esfor&#231;o (TEV), se indicada.</p>
    <p><italic>Resultado do Question&#225;rio de Claudica&#231;&#227;o de Edimburgo - </italic>Seguindo as normas publicadas originalmente, o resultado foi classificado como POSITIVO (presen&#231;a de claudica&#231;&#227;o) caso as respostas &#224;s perguntas tenham sido 1 = "sim", 2 = "n&#227;o", 3 = "sim", 5 = "geralmente desaparece em 10 minutos ou menos" e 6 = "panturrilha" e/ou "coxa" e/ou "regi&#227;o gl&#250;tea" (independentemente de terem sido assinalados outros lugares) ou NEGATIVO se assinalada qualquer combina&#231;&#227;o diferente da descrita acima. A quest&#227;o 4 n&#227;o &#233; utilizada para definir a presen&#231;a e sim a gravidade da claudica&#231;&#227;o: "N&#227;o" = Grau 1 (menor gravidade); e "Sim" = Grau 2 (maior gravidade). </p>
    <p>Os pacientes com question&#225;rio POSITIVO foram, ainda, classificados em portadores de "Claudica&#231;&#227;o t&#237;pica ou definitiva" (se na quest&#227;o 6 tivesse sido assinalada a "panturrilha", independentemente de terem sido assinaladas tamb&#233;m outras localiza&#231;&#245;es) e "Claudica&#231;&#227;o at&#237;pica" (caso n&#227;o tivesse sido assinalada "panturrilha", mas tivesse sido assinalada "coxa" e/ou "regi&#227;o gl&#250;tea", independentemente de outras localiza&#231;&#245;es). </p>
    <p><italic>Defini&#231;&#227;o de verdadeiramente positivo/negativo e falso positivo/negativo - </italic>Se o question&#225;rio de claudica&#231;&#227;o fosse NEGATIVO, se o ITB estivesse entre 0,91 e 1,40 bilateralmente e se n&#227;o houvesse antecedente de DAOP documentada, o mesmo era classificado como "verdadeiramente negativo"; caso o ITB estivesse <underline>&lt;</underline> 0,90 e/ou houvesse antecedente de DAOP, era classificado como "falso negativo". Question&#225;rio POSITIVO, ITB <underline>&lt;</underline> 0,90 e/ou documenta&#231;&#227;o de DAOP correspondia &#224; classifica&#231;&#227;o "verdadeiramente positivo". Se o ITB estivesse entre 0,91 e 1,40, se n&#227;o houvesse DAOP pr&#233;via e se o TEV fosse negativo, o mesmo era classificado como "falso positivo".</p>
    <p><italic>An&#225;lise estat&#237;stica</italic> - O desempenho do question&#225;rio foi avaliado por meio do programa SAS vers&#227;o 8.2, utilizado para calcular sensibilidade, especificidade, valor preditivo positivo (VPP), valor preditivo negativo (VPN) e acur&#225;cia com intervalos de confian&#231;a pelo m&#233;todo quadr&#225;tico de Fleiss (IC 95%). A acur&#225;cia diagn&#243;stica foi calculada dividindo-se a propor&#231;&#227;o de indiv&#237;duos classificados corretamente pelo question&#225;rio (soma de verdadeiramente positivos e verdadeiramente negativos) pelo total de indiv&#237;duos avaliados. As propor&#231;&#245;es foram comparadas utilizando-se o teste do qui-quadrado ou exato de Fisher, quando aplic&#225;vel, e as m&#233;dias foram comparadas por meio do teste <italic>t </italic>de <italic>Student</italic>.</p>
    <p>
      <bold>Resultados</bold>
    </p>
    <p><italic>Resultados gerais</italic> - A vers&#227;o em portugu&#234;s do Question&#225;rio de Claudica&#231;&#227;o de Edimburgo est&#225; apresentada na <xref ref-type="fig" rid="fig01">Figura 1</xref>.</p>
    <fig id="fig01">
      <graphic xlink:href="1678-4170-abc-88-05-0501-00001-gf01.jpg"/></fig>
    <p>A m&#233;dia de idade dos 217 indiv&#237;duos avaliados foi de 60 &#177; 11,5 anos (30 a 86 anos), com predom&#237;nio do sexo feminino (53,9%). A preval&#234;ncia de DAOP foi de 24% (n = 52) e de claudica&#231;&#227;o intermitente, de 25% (n = 55). </p>
    <p>No grupo com DAOP, os indiv&#237;duos eram mais velhos (65,8 &#177; 10,3 anos <italic>vs</italic> 58,2 &#177; 11,3 anos; p &lt; 0,0001), com predom&#237;nio do sexo masculino (61,5% <italic>vs</italic> 41%; p = 0,01). N&#227;o houve diferen&#231;a entre os grupos quanto ao n&#237;vel de escolaridade (7,38 &#177; 4,38 anos cursados <italic>vs</italic> 7,57 &#177; 3,87 anos cursados; p = 0,786) e quanto &#224; preval&#234;ncia de doen&#231;a ateroscler&#243;tica coexistente. Em rela&#231;&#227;o aos fatores de risco tradicionais, houve maior preval&#234;ncia de relato de diabetes, dislipidemia e tabagismo no grupo com DAOP. A preval&#234;ncia de claudica&#231;&#227;o, claudica&#231;&#227;o t&#237;pica e aus&#234;ncia de um ou mais pulsos dos tornozelos foi significativamente mais elevada nos portadores de DAOP (<xref ref-type="table" rid="tab01">tab. 1</xref>).</p>
    <table-wrap id="tab01">
      <graphic xlink:href="1678-4170-abc-88-05-0501-00001-gt01.jpg"/></table-wrap>
    <p><italic>Avalia&#231;&#227;o do desempenho da vers&#227;o em portugu&#234;s - </italic>A <xref ref-type="table" rid="tab02">tabela 2</xref> demonstra o desempenho diagn&#243;stico da vers&#227;o em portugu&#234;s do Question&#225;rio de Claudica&#231;&#227;o de Edimburgo. A sensibilidade da vers&#227;o em portugu&#234;s foi similar &#224; da vers&#227;o original (85%, IC 95% = 0,714-0,927 <italic>vs</italic> 91,3%, IC 95% = 0,881-0,945; p = 0,675) enquanto a especificidade foi menor (93%, IC 95% = 0,881-0,965 <italic>vs</italic> 99%, IC 95% = 0,989-1,00; p = 0,001). N&#227;o houve diferen&#231;a de desempenho entre idosos (<underline>&gt;</underline> 65 anos) e n&#227;o-idosos (&lt; 65 anos) (<xref ref-type="table" rid="tab03">tab. 3</xref>).</p>
    <table-wrap id="tab02">
      <graphic xlink:href="1678-4170-abc-88-05-0501-00001-gt02.jpg"/></table-wrap>
    <table-wrap id="tab03">
      <graphic xlink:href="1678-4170-abc-88-05-0501-00001-gt03.jpg"/></table-wrap>
    <p>
      <bold>Discuss&#227;o</bold>
    </p>
    <p>O Question&#225;rio de Claudica&#231;&#227;o de Edimburgo foi desenvolvido e validado originalmente em l&#237;ngua inglesa pelos professores Leng e Fowkes, da Universidade de Edimburgo, Esc&#243;cia, com o objetivo de melhorar a sensibilidade do Question&#225;rio de Claudica&#231;&#227;o da Organiza&#231;&#227;o Mundial da Sa&#250;de, publicado por Rose, em 1962<sup>9</sup>. Embora o question&#225;rio de Rose apresentasse alta especificidade (entre 90% e 100%), por utilizar crit&#233;rios rigorosos de claudica&#231;&#227;o, sua sensibilidade atingia n&#237;veis de at&#233; 9%<sup>10</sup>. Durante o processo de desenvolvimento do question&#225;rio de Edimburgo, o desempenho das nove quest&#245;es do question&#225;rio de Rose foram analisadas para se detectar aquelas que precisariam ser modificadas. Ao final do processo, o question&#225;rio foi reduzido a seis quest&#245;es, tendo sido adicionado um diagrama para marca&#231;&#227;o do local exato da dor, facilitando sua auto-aplica&#231;&#227;o.</p>
    <p>A vers&#227;o originalmente publicada por Leng e Fowkes<sup>11</sup>, em 1992, apresentou sensibilidade de 91% e especificidade de 99%, valores superiores aos obtidos pelo question&#225;rio de Rose<sup>11</sup>. Em 2000, Aboyans e cols.<sup>12</sup> publicaram uma vers&#227;o francesa do question&#225;rio, que apresentou sensibilidade de 86,5% e especificidade de 95,6%. Em 2002, em outra publica&#231;&#227;o de valida&#231;&#227;o da vers&#227;o francesa, Lacroix e cols.<sup>13</sup> encontraram diferen&#231;a no desempenho do question&#225;rio, especialmente em rela&#231;&#227;o a sua sensibilidade (sensibilidade de 47% e especificidade de 98,8%).</p>
    <p>A vers&#227;o em portugu&#234;s do Question&#225;rio de Claudica&#231;&#227;o de Edimburgo, apresentada neste estudo, mostrou sensibilidade de 85%, especificidade de 93%, valor preditivo positivo de 80%, valor preditivo negativo de 95% e acur&#225;cia de 91%. Em compara&#231;&#227;o com os dados da literatura, que demonstram varia&#231;&#245;es de 15% a 91% na sensibilidade e de 91,3% a 99% na especificidade quando utilizada a vers&#227;o inglesa do question&#225;rio em diferentes popula&#231;&#245;es, o desempenho da vers&#227;o em portugu&#234;s foi considerado muito bom<sup>14</sup>.</p>
    <p>Na compara&#231;&#227;o direta com a vers&#227;o original inglesa, a vers&#227;o em portugu&#234;s apresentou n&#237;veis de sensibilidade (85% <italic>vs</italic> 91%; p = 0,675) e de especificidade menores (93% <italic>vs</italic> 99%; p = 0,001), embora apenas a diferen&#231;a na especificidade tenha atingido signific&#226;ncia estat&#237;stica. Isso pode ter ocorrido pelas diferen&#231;as nas caracter&#237;sticas da popula&#231;&#227;o avaliada e no m&#233;todo de valida&#231;&#227;o utilizado. Na vers&#227;o inglesa, o diagn&#243;stico de DAOP foi realizado com base apenas na avalia&#231;&#227;o cl&#237;nica, o que aumentou a chance de concord&#226;ncia entre o resultado do question&#225;rio e a presen&#231;a de DAOP, uma vez que ambos t&#234;m como foco a DAOP sintom&#225;tica. Na vers&#227;o em portugu&#234;s foi utilizado m&#233;todo similar ao da vers&#227;o francesa<sup>11</sup>, optando-se por um m&#233;todo diagn&#243;stico mais objetivo, que &#233; a medida do ITB. Essa medida detecta tanto os pacientes sintom&#225;ticos como os assintom&#225;ticos, e que se aproxima mais da pr&#225;tica cl&#237;nica. Utilizando-se esse m&#233;todo, um caso assintom&#225;tico de DAOP seria classificado como "falso negativo" enquanto o diagn&#243;stico baseado apenas na hist&#243;ria cl&#237;nica teria chance maior de ser classificado como "verdadeiro negativo". Por outro lado, um caso sem DAOP com claudica&#231;&#227;o positiva pelo question&#225;rio poderia ser confirmado pela hist&#243;ria cl&#237;nica ("verdadeiro positivo"), mas n&#227;o pela medida do ITB ("falso positivo"). </p>
    <p>N&#227;o foram observadas diferen&#231;as significativas no desempenho da vers&#227;o em portugu&#234;s entre idosos e n&#227;o-idosos, o que permite que essa vers&#227;o seja utilizada tamb&#233;m nessa popula&#231;&#227;o de alto risco para DAOP.</p>
    <p>O bom desempenho da vers&#227;o em portugu&#234;s do Question&#225;rio de Claudica&#231;&#227;o de Edimburgo, apresentada neste estudo, na qual foram mantidos n&#237;veis de especificidade acima de 90%, sem perda de sua sensibilidade, permite que a mesma seja recomendada para uso na popula&#231;&#227;o brasileira tanto em pesquisas epidemiol&#243;gicas como na pr&#225;tica cl&#237;nica.</p>
    <p>
      <bold>Agradecimentos</bold>
    </p>
    <p>&#192; Libbs Farmac&#234;utica, pelo suporte log&#237;stico durante a I Campanha de Combate &#224; Doen&#231;a Arterial Obstrutiva Perif&#233;rica da SBC-Funcor, &#224; equipe multidisciplinar do Setor de Cardiogeriatria da Unifesp, ao Centro Universit&#225;rio Nove de Julho &#150; UNINOVE, que cedeu seu <italic>campus</italic> para a realiza&#231;&#227;o dos exames de ITB, e ao estat&#237;stico Frederico Moreira, que realizou as an&#225;lises estat&#237;sticas.</p>
    <p>
      <bold>Potencial Conflito de Interesses</bold>
    </p>
    <p>Declaro n&#227;o haver conflitos de interesses pertinentes.</p>
    <p>
      <fn id="end" fn-type="corresp">
        <label>
          <bold>Correspond&#234;ncia:</bold>
        </label>
        <p> Marcia Makdisse </p>
        <p> Rua Dr. Franco da Rocha, 205/51 </p>
        <p> 05015-040 &#150; S&#227;o Paulo, SP </p>
        <p> E-mail: </p>
        <p><email xlink:href="mmakdisse@yahoo.com">mmakdisse@yahoo.com</email> / </p>
        <p>
          <email xlink:href="mmakdisse@einstein.br">mmakdisse@einstein.br</email>
        </p>
      </fn>
    </p>
    <p>Artigo recebido em 13/07/06; revisado recebido em 06/11/06; aceito em 17/01/07.</p>
  </body>
  <back>
    <ref-list>
      <ref id="B1">
        <mixed-citation>1. Newman AB, Shemanski L, Manolio TA, Cushman    M, Mittelmark M, Polak JF, for the Cardiovascular Health Study Collaborative    Research Group. Ankle-Brachial Index as a Predictor of Cardiovascular Disease    and Mortality in the Cardiovascular Health Study. Arterioscler Thromb Vasc Biol.    1999; 19: 538-45.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>for the Cardiovascular Health Study Collaborative Research Group: Ankle-Brachial Index as a Predictor of Cardiovascular Disease and Mortality in the Cardiovascular Health Study</article-title>
          <source>Arterioscler Thromb Vasc Biol.</source>
          <date>
            <year>1999</year>
          </date>
          <fpage>538</fpage>
          <lpage>45</lpage>
          <volume>19</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Newman</surname>
              <given-names>AB</given-names>
            </name>
            <name>
              <surname>Shemanski</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Manolio</surname>
              <given-names>TA</given-names>
            </name>
            <name>
              <surname>Cushman</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Mittelmark</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Polak</surname>
              <given-names>JF</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B2">
        <mixed-citation>2. Newman AB, Tyrrell KS, Lewis HW. Mortality    over four years in SHEP participants with low ankle-brachial index. J Am Geriatr    Soc. 1997; 45: 1472-8.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Mortality over four years in SHEP participants with low ankle-brachial index</article-title>
          <source>J Am Geriatr Soc.</source>
          <date>
            <year>1997</year>
          </date>
          <fpage>1472</fpage>
          <lpage>8</lpage>
          <volume>45</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Newman</surname>
              <given-names>AB</given-names>
            </name>
            <name>
              <surname>Tyrrell</surname>
              <given-names>KS</given-names>
            </name>
            <name>
              <surname>Lewis</surname>
              <given-names>HW</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B3">
        <mixed-citation>3. Criqui MH, Denenber JO, Langer RD, Fronek    A. The epidemiology of peripheral arterial disease: importance of identifying    the population at risk. Vasc Med. 1997; 2: 221-6.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>The epidemiology of peripheral arterial disease: importance of identifying the population at risk</article-title>
          <source>Vasc Med.</source>
          <date>
            <year>1997</year>
          </date>
          <fpage>221</fpage>
          <lpage>6</lpage>
          <volume>2</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Criqui</surname>
              <given-names>MH</given-names>
            </name>
            <name>
              <surname>Denenber</surname>
              <given-names>JO</given-names>
            </name>
            <name>
              <surname>Langer</surname>
              <given-names>RD</given-names>
            </name>
            <name>
              <surname>Fronek</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B4">
        <mixed-citation>4. Hirsch A, Haskal ZJ, Hertzer NR, Bakal CW,    Creager MA, Halperin JL, et al. ACC/AHA Guidelines for the Management of Patients    with Peripheral Arterial Disease (Lower Extremity, Renal, Mesenteric, and Abdominal    Aortic): A Collaborative Report from the American Association of Vascular Surgery/Society    for Vascular Surgery, Society for Cardiovacular Angiography and Interventions,    Society for Vascular Medicine and Biology, Society of Interventional Radiology,    and the ACC/AHA Task Force on Practice Guidelines. Circulation. 2006; 113 (11):    e463-654.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>ACC/AHA Guidelines for the Management of Patients with Peripheral Arterial Disease (Lower Extremity, Renal, Mesenteric, and Abdominal Aortic): A Collaborative Report from the American Association of Vascular Surgery/Society for Vascular Surgery, Society for Cardiovacular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines</article-title>
          <source>Circulation</source>
          <date>
            <year>2006</year>
          </date>
          <fpage>e463</fpage>
          <lpage>654</lpage>
          <issue>11</issue>
          <volume>113</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Hirsch</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Haskal</surname>
              <given-names>ZJ</given-names>
            </name>
            <name>
              <surname>Hertzer</surname>
              <given-names>NR</given-names>
            </name>
            <name>
              <surname>Bakal</surname>
              <given-names>CW</given-names>
            </name>
            <name>
              <surname>Creager</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Halperin</surname>
              <given-names>JL</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B5">
        <mixed-citation>5. Passos VMA, Barreto SM, Guerra HL, Firmo JOA,    Vidigal PG, Lima-Costa MFF. The Bambu&#237; Health and Aging Study (BHAS):    prevalence of intermittent claudication in the aged population of the community    of Bambu&#237; and its associated factors. Arq Bras Cardiol. 2001; 77: 458-62.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>The Bambu&#237; Health and Aging Study (BHAS): prevalence of intermittent claudication in the aged population of the community of Bambu&#237; and its associated factors</article-title>
          <source>Arq Bras Cardiol.</source>
          <date>
            <year>2001</year>
          </date>
          <fpage>458</fpage>
          <lpage>62</lpage>
          <volume>77</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Passos</surname>
              <given-names>VMA</given-names>
            </name>
            <name>
              <surname>Barreto</surname>
              <given-names>SM</given-names>
            </name>
            <name>
              <surname>Guerra</surname>
              <given-names>HL</given-names>
            </name>
            <name>
              <surname>Firmo</surname>
              <given-names>JOA</given-names>
            </name>
            <name>
              <surname>Vidigal</surname>
              <given-names>PG</given-names>
            </name>
            <name>
              <surname>Lima-Costa</surname>
              <given-names>MFF</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B6">
        <mixed-citation>6. Guillemin F, Bombardier C, Beaton D. Cross-cultural    adaptation of health-related quality of life measures: literature review and    proposed guidelines. J Clin Epidemiol. 1993; 46: 1417-32.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Cross-cultural adaptation of health-related quality of life measures: literature review and proposed guidelines</article-title>
          <source>J Clin Epidemiol.</source>
          <date>
            <year>1993</year>
          </date>
          <fpage>1417</fpage>
          <lpage>32</lpage>
          <volume>46</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Guillemin</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Bombardier</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Beaton</surname>
              <given-names>D</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B7">
        <mixed-citation>7. Makdisse M. &#205;ndice tornozelo-braquial:    import&#226;ncia e uso na pr&#225;tica cl&#237;nica. S&#227;o Paulo:    Editora Segmento Farma; 2004. </mixed-citation>
        <element-citation publication-type="book">
          <source>&#205;ndice tornozelo-braquial: import&#226;ncia e uso na pr&#225;tica cl&#237;nica</source>
          <date>
            <year>2004</year>
          </date>
          <person-group person-group-type="author">
            <name>
              <surname>Makdisse</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B8">
        <mixed-citation>8. Weitz JI, Byrne J, Clagett JP, Farkouh ME,    Porter JM, Sackett DL. Diagnosis and treatment of chronic arterial insufficiency    of the lower extremities: a critical review. Circulation. 1996; 94 (11): 3026-49.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Diagnosis and treatment of chronic arterial insufficiency of the lower extremities: a critical review</article-title>
          <source>Circulation</source>
          <date>
            <year>1996</year>
          </date>
          <fpage>3026</fpage>
          <lpage>49</lpage>
          <issue>11</issue>
          <volume>94</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Weitz</surname>
              <given-names>JI</given-names>
            </name>
            <name>
              <surname>Byrne</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Clagett</surname>
              <given-names>JP</given-names>
            </name>
            <name>
              <surname>Farkouh</surname>
              <given-names>ME</given-names>
            </name>
            <name>
              <surname>Porter</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Sackett</surname>
              <given-names>DL</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B9">
        <mixed-citation>9. Rose GA. The diagnosis of ischaemic heart    pain and intermittent claudication in field surveys. Bull WHO. 1962;27:645-58.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>The diagnosis of ischaemic heart pain and intermittent claudication in field surveys</article-title>
          <source>Bull WHO</source>
          <date>
            <year>1962</year>
          </date>
          <fpage>645</fpage>
          <lpage>58</lpage>
          <volume>27</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Rose</surname>
              <given-names>GA</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B10">
        <mixed-citation>10. Criqui MH, Fronek A, Klauber MR, Barret-Connor    E, Gabriel S. The sensitivity, specificity, and predictive value of traditional    clinical evaluation of peripheral arterial disease: results from noninvasive    testing in a defined population. Circulation. 1985; 71: 516-22.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>The sensitivity, specificity, and predictive value of traditional clinical evaluation of peripheral arterial disease: results from noninvasive testing in a defined population</article-title>
          <source>Circulation</source>
          <date>
            <year>1985</year>
          </date>
          <fpage>516</fpage>
          <lpage>22</lpage>
          <volume>71</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Criqui</surname>
              <given-names>MH</given-names>
            </name>
            <name>
              <surname>Fronek</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Klauber</surname>
              <given-names>MR</given-names>
            </name>
            <name>
              <surname>Barret-Connor</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Gabriel</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B11">
        <mixed-citation>11. Leng GC, Fowkes FGR. The Edimburgh Claudication    Questionnaire: an improved version of the WHO/Rose Questionnaire for use in    epidemiological surveys. J Clin Epidemiol. 1992; 20: 384-92.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>The Edimburgh Claudication Questionnaire: an improved version of the WHO/Rose Questionnaire for use in epidemiological surveys</article-title>
          <source>J Clin Epidemiol.</source>
          <date>
            <year>1992</year>
          </date>
          <fpage>384</fpage>
          <lpage>92</lpage>
          <volume>20</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Leng</surname>
              <given-names>GC</given-names>
            </name>
            <name>
              <surname>Fowkes</surname>
              <given-names>FGR</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B12">
        <mixed-citation>12. Aboyans V, Lacroix P, Waruingi W, Bertin    F, Pesteil F, Vergnenegre A, et al. Traduction fran&#231;aise et validation    du questionnaire dEdimbourg pour le d&#233;pistage de la claudication intermittente.    Arch Mal Coeur. 2000; 93: 1173-7.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Traduction fran&#231;aise et validation du questionnaire d&#8217;Edimbourg pour le d&#233;pistage de la claudication intermittente</article-title>
          <source>Arch Mal Coeur.</source>
          <date>
            <year>2000</year>
          </date>
          <fpage>1173</fpage>
          <lpage>7</lpage>
          <volume>93</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Aboyans</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Lacroix</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Waruingi</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Bertin</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Pesteil</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Vergnenegre</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B13">
        <mixed-citation>13. Lacroix P, Aboyans V, Boissier C, Bressolette    L, Leger P. Validation dune traduction fran&#231;aise du questionnaire dEdimbourg    au sein dune population de consultants en m&#233;dicine g&#233;nerale.    Arch Mal Coeur. 2002; 95: 596-600.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Validation d&#8217;une traduction fran&#231;aise du questionnaire d&#8217;Edimbourg au sein d&#8217;une population de consultants en m&#233;dicine g&#233;nerale</article-title>
          <source>Arch Mal Coeur</source>
          <date>
            <year>2002</year>
          </date>
          <fpage>596</fpage>
          <lpage>600</lpage>
          <volume>95</volume>
          <person-group person-group-type="author">
            <name>
              <surname>Lacroix</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Aboyans</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Boissier</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Bressolette</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Leger</surname>
              <given-names>P</given-names>
            </name>
          </person-group>
        </element-citation>
      </ref>
      <ref id="B14">
        <label>14</label>
        <mixed-citation>14. TASC Working Group. Management of Peripheral Arterial Disease (PAD): TransAtlantic Inter-Society Consensus (TASC). J Vasc Surg. 2000; 31 (1, Part 2): S1-S288.</mixed-citation>
        <element-citation publication-type="journal">
          <article-title>Management of Peripheral Arterial Disease (PAD): TransAtlantic Inter-Society Consensus (TASC)</article-title>
          <source>J Vasc Surg.</source>
          <date>
            <year>2000</year>
          </date>
          <fpage>S1</fpage>
          <lpage>S288</lpage>
          <issue>1</issue>
          <volume>31</volume>
        </element-citation>
      </ref>
    </ref-list>
  </back>
  <sub-article article-type="translation" id="TRen" xml:lang="en">
    <front-stub>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Original Articles</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title xml:lang="en">Cross-cultural adaptation and validation of the Brazilian Portuguese version of the Edinburgh Claudication Questionnaire</article-title>
      </title-group>
      <abstract xml:lang="en">
        <p>OBJECTIVE: Translation, cultural adaptation and validation of the Brazilian Portuguese version of the Edinburgh Claudication Questionnaire (ECQ) a specific tool to assess intermittent claudication. METHODS: The Brazilian Portuguese version of the ECQ was developed after authorization by the University of Edinburgh. It was applied to 217 individuals: S&#227;o Paulo Capital District residents with complaints of leg pain. Individuals under research were invited through mass communication media to participate in the I Campaign to Fight Peripheral Arterial Disease (PAD). In stage 1, participants filled out the ECQ and another questionnaire on risk factors and cardiovascular history. In stage 2, participants had anthropometric measures and ankle-brachial index (ABI) at rest measured by vascular Doppler. In case of doubt, vascular treadmill test was applied (VTT). PAD condition was defined by ABI &lt; 0.90 and/or positive VTT and/or documented PAD. Statistical analysis - which included performance assessment and the comparison between proportions and means - was performed using SAS software, version 8.2. RESULTS: Mean age of participants was 60&#177;11.5 years, female sex predominated in the sample studied (53.4%). Sensitivity, specificity, positive predictive value, negative predictive value and accuracy were 85%, 93%, 80%, 95% and 91%, respectively. No differences in performance were found between elderly (&gt;65 years) and non-elderly subjects. CONCLUSION: The Brazilian Portuguese version of the Edinburgh claudication questionnaire maintained good sensitivity and specificity and can be recommended for screening of PAD in clinical practice and epidemiological research in Brazil.</p>
      </abstract>
      <kwd-group xml:lang="en">
        <kwd>Intermittent claudication</kwd>
        <kwd>questionaire</kwd>
        <kwd>translating</kwd>
        <kwd>transcultural adaptation</kwd>
      </kwd-group>
    </front-stub>
    <body>
      <p>
        <bold>ORIGINAL ARTICLE</bold>
      </p>
      <p>
        <bold>Cross-cultural adaptation and validation of the Brazilian Portuguese version of the Edinburgh Claudication Questionnaire</bold>
      </p>
      <p>
        <bold>Marcia Makdisse; Raimundo Nascimento Neto; Antonio Carlos Palandri Chagas; David Brasil; Jairo Lins Borges; Anderson Oliveira; Jos&#233; Gordillo; Gisele Balsalobre; Luciana Crozariol; Miriam Pinho; Rafaela Oliveira; Ana F&#225;tima Salles</bold>
      </p>
      <p>Comit&#234; de Doen&#231;a Arterial Perif&#233;rica do "Projeto Cora&#231;&#245;es do Brasil", SBC/Funcor, Setor de Cardiogeriatria-Disciplina de Cardiologia, Universidade Federal de S&#227;o Paulo, Hospital Israelita Albert Einstein &#150; S&#227;o Paulo, SP, Brazil</p>
      <p>
        <xref ref-type="corresp" rid="end-body2">Mailing address</xref>
      </p>
      <p>
        <bold>SUMMARY</bold>
      </p>
      <p><bold>OBJECTIVE:</bold> Translation, cultural adaptation and validation of the Brazilian Portuguese version of the Edinburgh Claudication Questionnaire (ECQ) a specific tool to assess intermittent claudication.</p>
      <p><bold>METHODS: </bold>The Brazilian Portuguese version of the ECQ was developed after authorization by the University of Edinburgh. It was applied to 217 individuals: S&#227;o Paulo Capital District residents with complaints of leg pain. Individuals under research were invited through mass communication media to participate in the I Campaign to Fight Peripheral Arterial Disease (PAD). In stage 1, participants filled out the ECQ and another questionnaire on risk factors and cardiovascular history. In stage 2, participants had anthropometric measures and ankle-brachial index (ABI) at rest measured by vascular Doppler. In case of doubt, vascular treadmill test was applied (VTT). PAD condition was defined by ABI <underline>&lt;</underline> 0.90 and/or positive VTT and/or documented PAD. Statistical analysis &#150; which included performance assessment and the comparison between proportions and means &#150; was performed using SAS software, version 8.2.</p>
      <p><bold>RESULTS: </bold>Mean age of participants was 60&#177;11.5 years, female sex predominated in the sample studied (53.4%). Sensitivity, specificity, positive predictive value, negative predictive value and accuracy were 85%, 93%, 80%, 95% and 91%, respectively. No differences in performance were found between elderly (<underline>&gt;</underline>65 years)and non-elderly subjects.</p>
      <p><bold>CONCLUSION: </bold>The Brazilian Portuguese version of the Edinburgh claudication questionnaire maintained good sensitivity and specificity and can be recommended for screening of PAD in clinical practice and epidemiological research in Brazil.</p>
      <p><bold>Key words: </bold>Intermittent claudication; questionaire; translating (process); transcultural adaptation.</p>
      <p>
        <bold>Introduction</bold>
      </p>
      <p>Peripheral Arterial Disease (PAD) is a result of artery lumen narrowing and stiffening in the lower limbs as part of the process of systemic atherosclerotic disease. Prevalence is high, and is associated to high risk for fatal and non-fatal cardiovascular events (death, myocardial infarction and cerebral vascular accident)<sup>1-2</sup>.</p>
      <p>Intermittent claudication is a classical symptom in the PAD condition. It occurs as a result of reduced blood flow to skeletal muscle tissue in lower limbs during exercise. Claudication is characterized by pain or discomfort in the calf, thigh, or gluteus region while walking. Symptoms disappear after less than 10 minutes at rest. Prevalence ranges from 0.4 to 14.4% in the general population depending on specific characteristics of the population being assessed (age, gender, region, among other factors) as well as of method used for diagnosis<sup>3</sup>.</p>
      <p>Ankle-Brachial Index (ABI) is the golden standard for PAD screening since it detects both symptomatic and asymptomatic conditions<sup>4</sup>. The use of claudication questionnaires, however, may help screening PAD both for epidemiologic research purposes and in clinical practice. Claudication questionnaires validated in Brazilian Portuguese are not available in this country today. The Bambu&#237; Project &#150; to assess the prevalence of intermittent claudication in residents of Bambu&#237;, in Minas Gerais State &#150; used a Brazilian Portuguese version of the World Health Organization Questionnaire. However, no published data were found on questionnaire validation or on performance in Brazilian Portuguese<sup>5</sup>.</p>
      <p>The purpose of the present study was the translation, cultural adaptation and validation of the Brazilian Portuguese version of the Edinburgh Claudication Questionnaire (ECQ). </p>
      <p>
        <bold>Methods</bold>
      </p>
      <p><italic>Translation of questionnaire -</italic> The translation and cultural adaptation of the original version into Brazilian Portuguese were performed based on methodology previously published<sup>6</sup>, following authorization by Professor Gerry Fowkes, from the University of Edinburgh. The translation was done independently by three members in our team and by two English teachers. As a result, five renditions were made available, with slight differences. The versions were then compared and discussed in a meeting where a consensual choice was made for Version 1. That version was then sent to three other independent translators who are fluent in English and who were not familiar with the original version for backtranslation into English. The three new versions were then compared to generate a consensual version in English (Version 2). When compared to the original version, Version 2 showed to be grammatically and semantically equivalent, which allowed Version 1 to be accepted by the group as the final version for the questionnaire in Brazilian Portuguese.</p>
      <p>
        <bold>Questionnaire Validation</bold>
      </p>
      <p><italic>Population</italic> - The Brazilian Portuguese version of the ECQ was applied to 217 individuals: S&#227;o Paulo Capital District residents with complaints of leg pain. Individuals under research were invited through mass communication media (television, radio, newspapers) to participate in the I Campaign to Fight Peripheral Arterial Disease (PAD). In Campaign phase 1 - carried out on July 20, 2004 &#150; all participants filled out the claudication questionnaire and another questionnaire on risk factors and cardiovascular history. Stage 2 &#150; in October-November, 2004 &#150; anthropometric measures and Ankle-brachial index (ABI) were taken, and vascular treadmill test (VTT) for threshold ABI values. PAD condition was defined by ABI <underline>&lt;</underline> 0.90 and/or positive VTT and/or documented PAD. All participants signed the Informed Consent Form.</p>
      <p><italic>ABI measure and calculation</italic> - To calculate ABI, systolic pressures of brachial arteries, dorsalis pedis and posterior tibial arteries were measured bilaterally after 5 minutes at rest in supine position using a handheld vascular Doppler and aneroid pressure equipment. Four cuff sizes were used (small size adult, median size adult, large size adult and thigh), based on right arm circumference at middle position between acromium and olecranium. ABI was calculated for each lower limb using arm highest systolic pressure as denominator, and ankle highest pressure as numerator<sup>7</sup>. </p>
      <p><italic>Vascular treadmill test</italic> - Vascular treadmill test was performed only for ABI threshold values (0.91 to 0.94). An incremental protocol was used for VTT on the treadmill at 3 km/hour, inclination from 0 to 15%, with 5% increment every 3 minutes. Pressures were measured with vascular Doppler in supine position at rest and after exercise. The test was considered POSITIVE for the diagnosis of PAD whenever ankle systolic pressure decrease measured at minute 1 after exercise was higher than or equal to 20% as compared to baseline, with baseline recovery time over 3 minutes<sup>8</sup>.</p>
      <p><italic>Exclusion criteria - </italic>Patients with ABI &gt; 1.40 (noncompressible arteries) and those with limitations or contra-indication to vascular treadmill test, if indicated. </p>
      <p><italic>Results from the Edinburgh Claudication Questionnaire</italic> - Following original guidelines, result was classified as POSITIVE (=presence of claudication) if responses to questions 1 = "yes" AND 2 = "no" AND 3= "yes" AND 5 = "usually disappear in 10 minutes or less" AND 6 = marked "calf" and/or "thigh" and/or "gluteus region" (irrespective of other sites having also been marked) or NEGATIVE for any combination that differed from the one just described. </p>
      <p>Question 4 is not used to define presence, but rather severity of claudication; if "No"=Grade 1 (=lower severity) and if "Yes"=Grade 2 (=higher severity). </p>
      <p>Patients with POSITIVE questionnaire were also classified as carriers of "Typical or definitive claudication" (if "calf" had been marked for question 6, irrespective of other sites also having been marked) and "Atypical claudication" (in case "calf" had not been marked, but "thigh" and/or "gluteus region" had been marked, irrespective of other site). </p>
      <p><italic>Definition for truly positive/negative and false positive/negative</italic> - If the claudication questionnaire was NEGATIVE, and ABI was between 0.91 and 1.40 bilaterally, with no history of documented PAD, classification would be "truly negative". If ABI was <underline>&lt;</underline> 0.90 with/without a previous history of PAD, "false negative". </p>
      <p>If questionnaire was POSITIVE and ABI <underline>&lt;</underline> 0.90 with/without documented PAD, questionnaire was classified as "truly positive". If ABI was between 0.91 and 1.40, with no previous PAD, and vascular treadmill test was negative, questionnaire classification was "false positive".</p>
      <p><italic>Statistical analysis - </italic>Questionnaire performance was assessed by SAS software, version 8.2 to calculate sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and accuracy with Fleiss Quadratic 95% CI. Diagnosis accuracy was calculated by dividing the number of individuals under correct classification on questionnaire (summing up of truly positives and truly negatives) by the total number of individuals under assessment. Proportions were then compared through chi-square test or Fisher Exact Test, whenever applicable, and means were compared by Student&#146;s "t" test.</p>
      <p>
        <bold>Results</bold>
      </p>
      <p><italic>Overall results</italic> - The Brazilian Portuguese Version of the Edinburgh Claudication Questionnaire can be found in <xref ref-type="fig" rid="fig01-body2">Figure 1</xref>.</p>
      <fig id="fig01-body2">
        <graphic xlink:href="1678-4170-abc-88-05-0501-00001-gf01-en.jpg"/></fig>
      <p>Mean age of the 217 individuals under assessment was 60 &#177; 11.5 years (30 to 86 years of age). Females were predominant (53.9%). Prevalence of PAD was 24% (n=52); prevalence of intermittent claudication was 25% (n=55). </p>
      <p>In the PAD group individuals were older (65.8 &#177; 10.3 years <italic>versus</italic> 58.2 &#177; 11.3 years, p&lt;0.0001). Males were predominant (61.5% <italic>versus</italic> 41%, p=0.01). No difference was found between the groups in regard to schooling (7.38 &#177; 4.38 years at school <italic>versus</italic> 7.57&#177;3.87 years at school, p=0.786) or coexisting atherosclerotic disease. As for traditional risk factors, higher prevalence was reported for diabetes, dyslipidemia, and smoking in the PAD group. Claudication prevalence, typical claudication and the lack of one or more ankle pulses was significantly higher in PAD individuals (<xref ref-type="table" rid="tab01-body2">Table 1</xref>).</p>
      <table-wrap id="tab01-body2">
        <graphic xlink:href="1678-4170-abc-88-05-0501-00001-gt01-en.jpg"/></table-wrap>
      <p><italic>Brazilian portuguese version: performance assessment</italic> - <xref ref-type="table" rid="tab02-body2">Table 2</xref> shows diagnostic performance of the Brazilian Portuguese Version of the Edinburgh Claudication Questionnaire. Portuguese version sensitivity was similar to that of original version (85%, CI95%=0.714-0.927 <italic>versus</italic> 91.3%, CI95%=0.881-0.945, p=0.675) whereas specificity was lower (93%, CI95%=0.881-0.965 <italic>versus</italic> 99%, CI95%=0.989-1.00, p=0.001). No difference was found in performance between the elderly (<underline>&gt;</underline> 65 years of age) and non-elderly (&lt;65 years of age) (<xref ref-type="table" rid="tab03-body2">Table 3</xref>).</p>
      <table-wrap id="tab02-body2">
        <graphic xlink:href="1678-4170-abc-88-05-0501-00001-gt02-en.jpg"/></table-wrap>
      <table-wrap id="tab03-body2">
        <graphic xlink:href="1678-4170-abc-88-05-0501-00001-gt03-en.jpg"/></table-wrap>
      <p>
        <bold>Discussion</bold>
      </p>
      <p>The Edinburg Claudication Questionnaire was originally developed and validated in English by Professors Leng and Fowkes, University of Edinburgh, In Scotland, with the objective of improving the sensitivity of the WHO Claudication Questionnaire published by Rose in 1962<sup>9</sup>. Although Rose Questionnaire had high specificity level (between 90% and 100%), sensitivity reached up to 9%<sup>10</sup> due to the strict claudication criteria used. As the Edinburgh Questionnaire was developed, performance of the nine questions from the Rose Questionnaire were analyzed to verify whether any changes were needed. At process ending, the questionnaire was reduced to six questions. A diagram was added for exact site of pain, thus making self-application easier.</p>
      <p>Sensitivity and specificity were 91% and 99% in the version originally published by Leng and Fowkes in 1992, higher than the valves obtained by the Rose Questionnaire<sup>11</sup>. In 2000, Aboyans and cols. published a French version of the questionnaire with 86.5% sensitivity and 95.6% specificity<sup>12</sup>. In 2002, in another publication of the French version validation, Lacroix and cols. found difference in questionnaire performance, especially in regard to sensitivity (sensitivity= 47% and specificity 98.8%)<sup>13</sup>.</p>
      <p>The Brazilian Portuguese version of the Edinburg Claudication Questionnaire presented in this study showed 85% sensitivity, 93% specificity, 80% positive predictive value, 95% negative predictive value, and 91% accuracy. When compared to data in literature &#150; showing a 15 at 91% range in sensitivity and a 91.3 to 99% range in specificity when the English version was used for different populations &#150; the performance of Brazilian Portuguese version was ranked as very good<sup>14</sup>.</p>
      <p>When compared to the original English version, the Brazilian Portuguese version showed lower sensitivity (85% <italic>versus</italic> 91%, p=0.675) and specificity (93% <italic>versus</italic> 99%, p=0.001) levels, although the difference in specificity did reach statistical significance. That may have occurred due to differences in population characteristics, and in the methodology used for validation. In the English version, PAD diagnosis was carried out based on clinical assessment only, which increased the chances of matching questionnaire results and the presence of PAD, since both focus symptomatic PAD. The Brazilian version used a methodology similar to the French version<sup>11</sup>, where the choice was made for a more objective diagnosis method (ABI measure), which detects both symptomatic and asymptomatic patients, and which is closer to clinical practice. Through this methodology, an asymptomatic PAD case would be classified as "false positive", whereas the diagnosis based on clinical history only would be more likely to be classified as "truly negative". On the other hand, a case reporting no PAD with positive claudication on questionnaire could be confirmed by clinical history ("truly positive"), but not by ABI measure ("false positive").</p>
      <p>No significant differences could be observed in the performance of the Brazilian Portuguese version among elderly and non-elderly, which allows it to be used for that high risk population for PAD as well.</p>
      <p>The good performance of the Brazilian Portuguese version of the Edinburgh Claudication Questionnare presented in this study &#150; where specificity levels were kept above 90% with no loss in sensitivity &#150; makes it recommendable for use in the Brazilian population both for epidemiologic research purposes as in clinical practice.</p>
      <p>
        <bold>Acknowledgments</bold>
      </p>
      <p>To Libbs Pharmaceuticals for logistic support during the "I SBC-Funcor Campaign to Fight PAD"; to the multidisciplinary team at the Cardiogeriatrics Sector at Unifesp, and to <italic>Centro Universit&#225;rio Nove de Julho &#150; UNINOVE</italic> &#150; for having made its facilities available for ABI exams; and to Frederico Moreira, the statistician who performed statistical analyses.</p>
      <p>
        <bold>Potential Conflict of Interest</bold>
      </p>
      <p>No potential conflict of interest relevant to this article was reported.</p>
      <p>
        <bold>References</bold>
      </p>
      <p>
        <fn id="end-body2" fn-type="corresp">
          <label>
            <bold>Mailing address:</bold>
          </label>
          <p> Marcia Makdisse</p>
          <p> Rua Dr. Franco da Rocha, 205/51</p>
          <p> 05015-040 &#150; S&#227;o Paulo, SP - Brazil</p>
          <p> E-mail: </p>
          <p><email xlink:href="mmakdisse@yahoo.com">mmakdisse@yahoo.com</email> / </p>
          <p>
            <email xlink:href="mmakdisse@einstein.br">mmakdisse@einstein.br</email>
          </p>
        </fn>
      </p>
      <p>Manuscript received July 13, 2006; revised manuscript received November 6, 2006; accepted January 17, 2007.</p>
    </body>
  </sub-article>
</article>
